top
Search terms
Results 1 - 2 of 2 - ordered by :
Ehjcvp

In patients without left ventricular dysfunction and/or overt HF, three large studies (Heart Outcomes Prevention Evaluation, HOPE trial,3 the European trial on Reduction Of cardiac events with ...

European Heart Journal - Cardiovascular Pharmacotherapy, EDITORIAL, Stefania Paolillo, Pasquale Perrone Filardi

Date : 01/04/2015
Ehjcvp

Introduction Dual antiplatelet therapy (DAPT), consisting of the combination of aspirin and a P2Y12 inhibitor, is recommended by guidelines for up to 12 months in patients with acute coronary ...

European Heart Journal - Cardiovascular Pharmacotherapy, ORIGINAL ARTICLE, Gianluigi Savarese, Stefano Savonitto, Lars H. Lund, Stefania Paolillo, Caterina Marciano, Santo Dellegrottaglie, Antonio ...

Date : 21/04/2016